Impact of the Opioid Epidemic on Drug Testing.
Ther Drug Monit
; 43(1): 14-24, 2021 02 01.
Article
en En
| MEDLINE
| ID: mdl-33230043
ABSTRACT
BACKGROUND:
This review provides a description of how the opioid epidemic has impacted drug testing.METHODS:
Four major service areas of drug testing were considered, including emergency response, routine clinical care, routine forensics, and death investigations.RESULTS:
Several factors that the opioid epidemic has impacted in drug testing are discussed, including specimens, breadth of compounds recommended for testing, time to result required for specific applications, analytical approaches, interpretive support requirements, and examples of published practice guidelines.CONCLUSIONS:
Both clinical and forensic laboratories have adapted practices and developed new testing approaches to respond to the opioid epidemic. Such changes are likely to continue evolving in parallel with changes in both prescription and nonprescription opioid availability and use patterns, as well as emerging populations that are affected by the "waves" of the opioid epidemic.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Detección de Abuso de Sustancias
/
Sobredosis de Droga
/
Epidemia de Opioides
/
Trastornos Relacionados con Opioides
Tipo de estudio:
Guideline
/
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Ther Drug Monit
Año:
2021
Tipo del documento:
Article